Holen Sie sich die Stockscreener-App
98.50
4.05%
3.895
Finanzdaten der Axsome Therapeutics Inc-Aktie (AXSM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
4.85%
75.00
|
71.53 | 57.79 | 46.70 | 94.58 |
Operating Expenses
|
16.21%
142.27
|
169.80 | 119.91 | 111.76 | 100.95 |
| Benefits Costs and Expenses |
15.92%
143.36
|
170.51 | 120.67 | 114.49 | 103.21 |
| Costs And Expenses |
16.21%
142.27
|
169.80 | 119.91 | 111.76 | 100.95 |
| Operating Income/Loss |
31.54%
-67.28
|
-98.27 | -62.12 | -65.06 | -6.374 |
| Income/Loss From Continuing Operations Before Tax |
30.94%
-68.36
|
-98.98 | -62.88 | -67.79 | -8.638 |
| Income Tax Expense/Benefit |
100.00%
-
|
-0.325 | -0.678 | -0.617 | 2.58 |
| Income/Loss From Continuing Operations After Tax |
30.71%
-68.36
|
-98.65 | -62.20 | -67.17 | -11.22 |
|
Net Income/Loss
|
30.71%
-68.36
|
-98.65 | -62.20 | -67.17 | -11.22 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7,284%
47.39
|
0.6418 | 47.12 | 43.67 | 43.52 |
| Diluted Average Shares |
7,284%
47.39
|
0.6418 | 47.12 | 43.67 | 43.52 |
| Basic Earnings Per Share |
32.39%
-1.44
|
-2.13 | -1.32 | -1.54 | -0.26 |
| Diluted Earnings Per Share |
32.39%
-1.44
|
-2.13 | -1.32 | -1.54 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):